{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T14:11:28Z","timestamp":1780927888361,"version":"3.54.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.ijantimicag.2020.105919","type":"journal-article","created":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T11:51:37Z","timestamp":1581594697000},"page":"105919","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Contribution of \u03b2-lactamase and efflux pump overproduction to tazobactam-piperacillin resistance in clinical isolates of Escherichia coli"],"prefix":"10.1016","volume":"55","author":[{"given":"Yuuki","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toyotaka","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukari","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chie","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-ichi","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2020.105919_bib0001","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2165\/00003495-198428050-00002","article-title":"Piperacillin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use","volume":"28","author":"Holmes","year":"1984","journal-title":"Drugs"},{"key":"10.1016\/j.ijantimicag.2020.105919_bib0002","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1128\/CMR.18.4.657-686.2005","article-title":"Extended-spectrum \u03b2-lactamases: a clinical update","volume":"18","author":"Paterson","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2020.105919_bib0003","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jiac.2016.03.001","article-title":"Community spread of extended-spectrum \u03b2-lactamase-producing bacteria detected in social insurance hospitals throughout Japan","volume":"22","author":"Shibasaki","year":"2016","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.ijantimicag.2020.105919_bib0004","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1128\/CMR.00037-09","article-title":"Three decades of \u03b2-lactamase inhibitors","volume":"23","author":"Drawz","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2020.105919_bib0005","series-title":"The JAID\/JSC Guide to Clinical Management of Infectious Diseases 2019.","year":"2014"},{"key":"10.1016\/j.ijantimicag.2020.105919_bib0006","unstructured":"Japan Nosocomial Infections Surveillance. JANIS Open Report. 2018."},{"key":"10.1016\/j.ijantimicag.2020.105919_bib0007","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1128\/AAC.39.2.308","article-title":"Development of test panel of \u03b2-lactamases expressed in a common Escherichia coli host background for evaluation of new \u03b2-lactam antibiotics","volume":"39","author":"Bradford","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2020.105919_bib0008","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.1128\/AAC.46.12.4035-4037.2002","article-title":"Promoters P3, Pa\/Pb, P4, and P5 upstream from blaTEM genes and their relationship to \u03b2-lactam resistance","volume":"46","author":"Lartigue","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2020.105919_bib0009","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3389\/fmicb.2019.00833","article-title":"Piperacillin-tazobactam (TZP) resistance in Escherichia coli due to hyperproduction of TEM-1 \u03b2-lactamase mediated by the promoter Pa\/Pb","volume":"10","author":"Zhou","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijantimicag.2020.105919_bib0010","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00583-18","article-title":"Extensive gene amplification as a mechanism for piperacillin-tazobactam resistance in Escherichia coli","volume":"9","author":"Schechter","year":"2018","journal-title":"MBio"},{"key":"10.1016\/j.ijantimicag.2020.105919_bib0011","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jiac.2015.01.006","article-title":"Comparison of the risk of acquiring in vitro resistance to doripenem and tazobactam\/piperacillin by CTX-M-15-producing Escherichia coli","volume":"21","author":"Horiyama","year":"2015","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.ijantimicag.2020.105919_bib0012","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01848-16","article-title":"CTX-M-190, a novel \u03b2-lactamase resistant to tazobactam and sulbactam, identified in an Escherichia coli clinical isolate","volume":"61","author":"Shen","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2020.105919_bib0013","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.3389\/fmicb.2018.01422","article-title":"Interplay between membrane permeability and enzymatic barrier leads to antibiotic-dependent resistance in Klebsiella pneumoniae","volume":"9","author":"Nicolas-Chanoine","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijantimicag.2020.105919_bib0014","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.resmic.2010.03.006","article-title":"Proteomic analysis of Escherichia coli with experimentally induced resistance to piperacillin\/tazobactam","volume":"161","author":"dos Santos","year":"2010","journal-title":"Res Microbiol"},{"key":"10.1016\/j.ijantimicag.2020.105919_bib0015","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1128\/AAC.01275-10","article-title":"Klebsiella pneumoniae outer membrane porins OmpK35 and OmpK36 play roles in both antimicrobial resistance and virulence","volume":"55","author":"Tsai","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2020.105919_bib0016","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1128\/AAC.45.12.3548-3554.2001","article-title":"Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae","volume":"45","author":"Thomson","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2020.105919_bib0017","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1469-0691.2009.02893.x","article-title":"Comparative assessment of inoculum effects on the antimicrobial activity of amoxycillin-clavulanate and piperacillin-tazobactam with extended-spectrum \u03b2-lactamase-producing and extended-spectrum \u03b2-lactamase-non-producing Escherichia coli isolates","volume":"16","author":"Lopez-Cerero","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2020.105919_bib0018","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01654-16","article-title":"Tigecycline nonsusceptibility occurs exclusively in fluoroquinolone-resistant Escherichia coli clinical isolates, including the major multidrug-resistant lineages O25b:H4-ST131-H30R and O1-ST648","volume":"61","author":"Sato","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2020.105919_bib0019","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000336129","article-title":"Prevalence of fluoroquinolone-resistant Escherichia coli O25:H4-ST131 (CTX-M-15-nonproducing) strains isolated in Japan","volume":"58","author":"Yokota","year":"2012","journal-title":"Chemotherapy"},{"key":"10.1016\/j.ijantimicag.2020.105919_bib0020","doi-asserted-by":"crossref","first-page":"6640","DOI":"10.1073\/pnas.120163297","article-title":"One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products","volume":"97","author":"Datsenko","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijantimicag.2020.105919_bib0021","series-title":"Performance standards for antimicrobial susceptibility testing; 27th informational supplement. CLSI M100-S27","year":"2017"},{"key":"10.1016\/j.ijantimicag.2020.105919_bib0022","doi-asserted-by":"crossref","first-page":"5860","DOI":"10.1128\/JCM.43.12.5860-5864.2005","article-title":"Analysis of a uropathogenic Escherichia coli clonal group by multilocus sequence typing","volume":"43","author":"Tartof","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2020.105919_bib0023","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.1128\/AEM.66.10.4555-4558.2000","article-title":"Rapid and simple determination of the Escherichia coli phylogenetic group","volume":"66","author":"Clermont","year":"2000","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.ijantimicag.2020.105919_bib0024","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.diagmicrobio.2006.08.007","article-title":"Determination of Escherichia coli O types by allele-specific polymerase chain reaction: application to the O types involved in human septicemia","volume":"57","author":"Clermont","year":"2007","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.105919_bib0025","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.mimet.2010.04.008","article-title":"A multiplex PCR method to detect 14 Escherichia coli serogroups associated with urinary tract infections","volume":"82","author":"Li","year":"2010","journal-title":"J Microbiol Methods"},{"key":"10.1016\/j.ijantimicag.2020.105919_bib0026","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2180-5-4","article-title":"Genetical and functional investigation of fliC genes encoding flagellar serotype H4 in wildtype strains of Escherichia coli and in a laboratory E. coli K-12 strain expressing flagellar antigen type H48","volume":"5","author":"Beutin","year":"2005","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.ijantimicag.2020.105919_bib0027","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3389\/fmicb.2013.00125","article-title":"Fluoroquinolone resistance mechanisms in an Escherichia coli isolate, HUE1, without quinolone resistance-determining region mutations","volume":"4","author":"Sato","year":"2013","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijantimicag.2020.105919_bib0028","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1099\/jmm.0.033910-0","article-title":"Effect of spacer sequences between blaCTX-M and ISEcp1 on blaCTX-M expression","volume":"60","author":"Ma","year":"2011","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2020.105919_bib0029","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jbiotec.2005.11.014","article-title":"Absolute and relative QPCR quantification of plasmid copy number in Escherichia coli","volume":"123","author":"Lee","year":"2006","journal-title":"J Biotechnol"},{"key":"10.1016\/j.ijantimicag.2020.105919_bib0030","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1128\/CMR.00125-13","article-title":"Escherichia coli ST131, an intriguing clonal group","volume":"27","author":"Nicolas-Chanoine","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2020.105919_bib0031","doi-asserted-by":"crossref","first-page":"195","DOI":"10.12688\/f1000research.10609.1","article-title":"Escherichia coli ST131: a multidrug-resistant clone primed for global domination","volume":"6","author":"Pitout","year":"2017","journal-title":"F1000Res"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857920300625?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857920300625?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:35:07Z","timestamp":1760376907000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857920300625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0924857920300625"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105919","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contribution of \u03b2-lactamase and efflux pump overproduction to tazobactam-piperacillin resistance in clinical isolates of Escherichia coli","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105919","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105919"}}